Skip to main content
. 2019 Mar;189(3):648–664. doi: 10.1016/j.ajpath.2018.11.019

Table 1.

Experimental Groups for FSD Surgery

Experimental group at 8 weeks Animals, n Scaffold volume, μL Total dose
BMP2, μg (600 μg/mL) shRNA lentivirus, pfu (1 × 107 pfu/mL)
PBS (control) 5 3.5 0 0
BMP2 5 3.5 2.1 0
BMP2 + shControl 5 3.5 2.1 35,000
BMP2 + shPPARγ 5 3.5 2.1 35,000

FSD, femoral segmental defect; pfu, plaque-forming unit.